New NCCN Guidelines for Patients® Now Available for Esophageal Cancer
NCCN announces the availability of the NCCN Guidelines for Patients®: Esophageal Cancer through generous support from the Honorable Ellen O`Kane Tauscher.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network® (NCCN®), through generous support from the Honorable Ellen O`Kane Tauscher, announces the availability of the latest addition to the library of NCCN Guidelines for Patients®; the NCCN Guidelines for Patients®: Esophageal Cancer is now available free-of-charge at NCCN.com and NCCN.org.
The NCCN Guidelines for Patients®, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are designed to provide people with cancer and their caregivers state-of-the-art treatment information in easy-to-understand language.
According to the American Cancer Society (ACS), one distinct challenge faced by individuals diagnosed with esophageal cancer is that the disease is often detected at a late stage, making treatment difficult. In 2012, the National Cancer Institute (NCI) estimated that more than 17,000 people would be diagnosed with esophageal cancer in the United States, and more than 15,000 of them would die as a result of the disease.
NCCN Guidelines for Patients®: Esophageal Cancer is written for patients diagnosed with any stage of the disease and their caregivers, and is supported by a donation from Ms. Tauscher, Strategic Advisor for Baker, Donelson, Bearman, Caldwell & Berkowitz, PC; Former Under Secretary of State for Arms Control & International Security; Former Member of Congress; Chair of the NCCN Foundation Board of Directors; and esophageal cancer survivor.
I made a personal commitment to make available the NCCN Guidelines for Patients: Esophageal Cancer and get it into the hands of the many people affected each year by this diagnosis, said Ms. Tauscher. This is my way to `pay it forward` and help all cancer patients become cancer survivors.
The NCCN Guidelines for Patients®: Esophageal Cancer is dedicated to the memory of Marie O`Kane, Ms. Tauscher`s paternal grandmother, who was diagnosed with esophageal cancer in 1973.
NCCN is pleased to announce the availability of the NCCN Guidelines for Patients for Esophageal Cancer, said Robert W. Carlson, MD, CEO, NCCN. The dedication of the NCCN Foundation, in conjunction with the support and enthusiasm of individuals like Ms. Tauscher, truly allow for the empowerment of patients and their caregivers, through the creation and dissemination of world-class treatment recommendations. NCCN is honored to receive support from Ms. Tauscher for this project.
The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms that address appropriate management options from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients® translate the professional Guidelines in a clear, step-by-step manner that people can use as the basis for making decisions and discussing treatment options with their physicians.
NCCN currently offers 12 additional NCCN Guidelines for Patients®, including Breast, Colon, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers, Caring for Adolescents and Young Adults (AYA), Chronic Myelogenous Leukemia, Malignant Pleural Mesothelioma, Melanoma, Multiple Myeloma, and Lung Cancer Screening. Print versions are available for certain disease types. Please e-mail email@example.com to request free copies.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.
The NCCN Member Institutions are:
- Fred & Pamela Buffett Cancer Center
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
- City of Hope Comprehensive Cancer Center
- Dana-Farber/Brigham and Women's Cancer Center
Massachusetts General Hospital Cancer Center
- Duke Cancer Institute
- Fox Chase Cancer Center
- Huntsman Cancer Institute at the University of Utah
- Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Mayo Clinic Cancer Center
- Memorial Sloan Kettering Cancer Center
- Moffitt Cancer Center
- The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
- Roswell Park Cancer Institute
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
- St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
- Stanford Cancer Institute
- University of Alabama at Birmingham Comprehensive Cancer Center
- UC San Diego Moores Cancer Center
- UCSF Helen Diller Family Comprehensive Cancer Center
- University of Colorado Cancer Center
- University of Michigan Comprehensive Cancer Center
- The University of Texas MD Anderson Cancer Center
- Vanderbilt-Ingram Cancer Center
- Yale Cancer Center/Smilow Cancer Hospital